Jay Bhattacharya, the director of the National Institutes of Health (NIH), recently announced during an interview that the last Beagle facility on the NIH campus has been shut down.
This announcement coincided with an investigation into the funding of Beagle experiments, notably after Elon Musk took over the Office of Efficiency (DOGE). According to a report from the White Coat Waste (WCW) project, which details troubling practices in the lab, over 2,000 beagles were subjected to severe experimentation, including being injected with bacteria and placed in life-threatening situations.
Following the closure, Anthony Berotti, the president of WCW, expressed appreciation for President Donald Trump’s efforts to put an end to such animal experiments, emphasizing the need for the government to stop funding these practices.
“Taxpayers and pet owners shouldn’t be required to finance NIH beagle abuse,” Berotti stated. He praised the decision to cut funding and reiterated the group’s commitment to halting all dog experiments, calling the situation madness.
During his earlier tenure, the Trump administration had also shut down the most significant cat lab in the U.S. Bhattacharya mentioned receiving flowers from PETA after the closure, indicating some support from animal rights advocates. He noted that while NIH directors often face threats, receiving flowers seemed more supportive.
PETA has criticized various government-sponsored experiments and pushed for reform regarding animal testing practices. Following the facility’s closure, Kathy Guillermo, Senior Vice President at PETA, highlighted the importance of this step for modern science.
The company Envigo, which was previously involved with the beagles, had faced legal challenges for its treatment of the dogs, leading to significant changes in its operational practices.
Guillermo concluded with optimism, stating that although the closure was a victory, more work is needed to prevent future animal testing, expressing eagerness for what the future holds.
At this point, neither the White House nor the NIH has responded to requests for commentary regarding this matter.
